Imigra 10 mg (Capsule)

Unit Price: ৳ 5.02 (5 x 10: ৳ 251.00)
Strip Price: ৳ 50.20

Medicine Details

Title

  • Imigra

Categories

  • Medicine
  • Pharmaceuticals
  • Healthcare

Description

  • Prophylaxis of classic (with aura) or common (without aura) migraine
  • Symptomatic treatment of vestibular vertigo
  • Peripheral Vascular Disease (PVD) treatment
  • Motion sickness treatment
  • Refractory epilepsy resistant to conventional antiepileptic therapy

Color Options

  • N/A

Dimensions

  • N/A

Functions

  • Prophylaxis of classic and common migraine
  • Symptomatic treatment of vestibular vertigo
  • Peripheral Vascular Disease (PVD) treatment
  • Motion sickness treatment
  • Refractory epilepsy resistant to conventional antiepileptic therapy

Materials

  • Flunarizine

Technical Specifications

  • Selective calcium channel antagonist
  • Binds at an affinity of 99% to plasma protein

Design Elements

  • N/A

Usability Features

  • Drowsiness and/or fatigue may occur
  • May lead to weight gain and/or increased appetite
  • May reveal Parkinsonism especially in predisposed patients such as the elderly
  • Not suited for aborting a migraine attack
  • Cautioned against driving motor vehicles or performing other potentially hazardous tasks
  • Storage temperature below 30°C

Dosage & Administration

  • Starting Dose: 10 mg at night in patients less than 65 years of age and 5 mg daily in patients older than 65 years
  • Maintenance Treatment: Dose should be decreased to 5 days treatment at the same daily dose with two successive medicine-free days every week
  • Peripheral Vascular disease: 10 mg twice daily, up to 30 mg per day if required
  • Vertigo & motion sickness: 10-20 mg daily for adults and 5 mg daily for children (>40 kg)
  • Epileptic seizure: 15-20 mg daily in adults and 5 to 10 mg daily for children as add-on therapy

Interaction

  • Galactorrhoea has been reported in few women on oral contraceptives within the first two months of Imigra treatment
  • Hepatic enzyme inducers such as Carbamazepine and Phenytoin may interact with Imigra by increasing its metabolism

Contraindications

  • Hypersensitivity to Flunarizine
  • History of depressive illness
  • Pre-existing symptoms of Parkinson's disease or other extrapyramidal disorders

Side Effects

  • Drowsiness and/or fatigue
  • Weight gain and/or increased appetite
  • Adverse experiences reported during chronic treatment with Imigra: depression, extrapyramidal symptoms, heartburn, nausea, gastralgia, insomnia, anxiety, galactorrhoea, dry mouth, muscle ache, skin rash

Pregnancy & Lactation

  • Safety not established

Precautions & Warnings

  • May lead to drowsiness aggravated by simultaneous intake of alcohol or other central nervous system depressants
  • Not suited for aborting a migraine attack
  • May reveal Parkinsonism especially in predisposed patients such as the elderly
  • Cautioned against driving motor vehicles or performing other potentially hazardous tasks
  • Used with caution in predisposed patients such as the elderly

Therapeutic Class

  • Miscellaneous prophylactic migraine preparations

Storage Conditions

  • Keep below 30°C temperature
  • Away from light & moisture
  • Keep out of the reach of children

Related Brands